X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALKEM LABORATORIES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALKEM LABORATORIES ABBOTT INDIA/
ALKEM LABORATORIES
 
P/E (TTM) x 33.3 - - View Chart
P/BV x 8.3 6.2 134.4% View Chart
Dividend Yield % 0.8 0.7 115.3%  

Financials

 ABBOTT INDIA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
ALKEM LABORATORIES
Mar-16
ABBOTT INDIA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6,0151,589 378.5%   
Low Rs3,7071,232 300.9%   
Sales per share (Unadj.) Rs1,236.9417.5 296.3%  
Earnings per share (Unadj.) Rs122.256.3 217.0%  
Cash flow per share (Unadj.) Rs129.064.7 199.3%  
Dividends per share (Unadj.) Rs35.0012.70 275.6%  
Dividend yield (eoy) %0.70.9 80.0%  
Book value per share (Unadj.) Rs521.2292.9 177.9%  
Shares outstanding (eoy) m21.25119.57 17.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.93.4 116.3%   
Avg P/E ratio x39.825.1 158.8%  
P/CF ratio (eoy) x37.721.8 172.9%  
Price / Book Value ratio x9.34.8 193.7%  
Dividend payout %28.622.6 127.0%   
Avg Mkt Cap Rs m103,296168,653 61.2%   
No. of employees `0003.0NA-   
Total wages/salary Rs m3,3709,171 36.7%   
Avg. sales/employee Rs Th8,891.8NM-  
Avg. wages/employee Rs Th1,140.0NM-  
Avg. net profit/employee Rs Th878.3NM-  
INCOME DATA
Net Sales Rs m26,28449,915 52.7%  
Other income Rs m5041,645 30.7%   
Total revenues Rs m26,78951,561 52.0%   
Gross profit Rs m3,6658,482 43.2%  
Depreciation Rs m1441,006 14.4%   
Interest Rs m8671 1.2%   
Profit before tax Rs m4,0178,451 47.5%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4211,606 88.5%   
Profit after tax Rs m2,5966,731 38.6%  
Gross profit margin %13.917.0 82.1%  
Effective tax rate %35.419.0 186.1%   
Net profit margin %9.913.5 73.2%  
BALANCE SHEET DATA
Current assets Rs m14,44627,062 53.4%   
Current liabilities Rs m4,72515,324 30.8%   
Net working cap to sales %37.023.5 157.3%  
Current ratio x3.11.8 173.1%  
Inventory Days Days5167 77.3%  
Debtors Days Days2041 47.4%  
Net fixed assets Rs m1,11312,610 8.8%   
Share capital Rs m213239 88.9%   
"Free" reserves Rs m10,80834,490 31.3%   
Net worth Rs m11,07635,027 31.6%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m16,24154,387 29.9%  
Interest coverage x497.013.6 3,653.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.9 176.3%   
Return on assets %16.013.6 117.8%  
Return on equity %23.419.2 122.0%  
Return on capital %36.324.9 146.2%  
Exports to sales %0.612.9 4.7%   
Imports to sales %12.63.1 409.6%   
Exports (fob) Rs m1626,461 2.5%   
Imports (cif) Rs m3,3221,540 215.7%   
Fx inflow Rs m2686,563 4.1%   
Fx outflow Rs m3,9273,012 130.4%   
Net fx Rs m-3,6593,552 -103.0%   
CASH FLOW
From Operations Rs m2,5147,259 34.6%  
From Investments Rs m-8001,864 -42.9%  
From Financial Activity Rs m-803-9,273 8.7%  
Net Cashflow Rs m912-150 -607.9%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 33.1 23.9%  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 0.0 -  
Shareholders   18,270 68,381 26.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SANOFI INDIA  TORRENT PHARMA  STRIDES SHASUN LTD  CIPLA  ASTRAZENECA PHARMA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 16, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS